Skip to main content
logo
Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
6.81
-0.09 (-1.30%)
Sep 29, 2026, 2:08 PM EDT - Market open

Kyntra Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
283653871,5051,307
Market Cap Growth
-44.96%-33.43%-38.78%-94.21%15.15%-61.27%
Enterprise Value
-64-2857481,225960
Last Close Price
6.908.7813.2422.16400.50352.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
0.150.19----
Forward PE
-201.74201.74201.74201.74201.74
PS Ratio
6.055.521.801.8610.705.56
PB Ratio
-7.94-0.29-0.54-1017.035.71
P/TBV Ratio
-----6.25

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--1.931.038.704.08

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-4.37-0.49-1.03-72.280.51
Net Debt / Equity Ratio
11.21-15.51-0.220.22212.86-1.26
Net Debt / EBITDA Ratio
1.831.56-0.310.111.090.86
Net Debt / FCF Ratio
2.4014.43-0.290.112.113.29
Asset Turnover
0.030.040.090.090.200.29
Inventory Turnover
7.506.9810.9510.248.4018.90
Quick Ratio
2.543.190.601.091.601.91
Current Ratio
2.693.391.471.521.802.10
Return on Equity (ROE)
-----258.01%-86.50%
Return on Assets (ROA)
-22.50%-16.96%-25.66%-40.48%-27.19%-27.22%
Return on Capital Employed (ROCE)
-77.30%-50.20%-161.20%-162.60%-89.50%-63.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
655.69%516.49%-89.17%-326.11%-19.51%-22.19%
FCF Yield
-136.23%-13.55%-259.13%-364.32%-9.94%-6.69%
Buyback Yield / Dilution
-0.32%-1.02%-2.82%-3.98%-1.33%-2.78%